Cargando…
Nomograms Predicting Survival of Cervical Cancer Patients Treated With Concurrent Chemoradiotherapy Based on the 2018 FIGO Staging System
BACKGROUND: In 2018, a revised staging system was released for cervical cancer, which defined pelvic and paraaortic lymph node metastasis as stages IIIC1 and IIIC2, respectively. In this study, we constructed and validated nomograms to predict the 3- and 5-year survival of patients with cervical can...
Autores principales: | Meng, Qingyu, Wang, Weiping, Liu, Xiaoliang, Wang, Dunhuang, Zhang, Fuquan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9130963/ https://www.ncbi.nlm.nih.gov/pubmed/35646645 http://dx.doi.org/10.3389/fonc.2022.870670 |
Ejemplares similares
-
Validation of the 2018 FIGO Staging System of Cervical Cancer for Stage III Patients with a Cohort from China
por: Liu, Xiaoliang, et al.
Publicado: (2020) -
Nomograms predicting survival and patterns of failure in patients with cervical cancer treated with concurrent chemoradiotherapy: A special focus on lymph nodes metastases
por: Wang, Weiping, et al.
Publicado: (2019) -
Evaluation of the efficacy of prophylactic extended field irradiation in the concomitant chemoradiotherapy treatment of locally advanced cervical cancer, stage IIIB in the 2018 FIGO classification
por: Meng, Qingyu, et al.
Publicado: (2019) -
The 100 Most Cited Papers in Radiotherapy or Chemoradiotherapy for Cervical Cancer: 1990–2020
por: Wang, Weiping, et al.
Publicado: (2021) -
A Risk Stratification for Patients with Cervical Cancer in Stage IIIC1 of the 2018 FIGO Staging System
por: Liu, Xiaoliang, et al.
Publicado: (2020)